ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. More >>
Receive E-mail Alerts|
|Alerts are e-mailed to you whenever certain new company information is posted to this site.|
|12/18/13||ResMed Announces Conference Call And Webcast To Discuss Second Quarter 2014 Results|
|SAN DIEGO, Dec. 18, 2013 /PRNewswire/ -- RESMED INC. (NYSE: RMD) announced today that on Thursday, January 23, 2014, it will release its results for the second quarter and six months of fiscal year 2014, ended December 31, 2013. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a conference call and webcast to review its results, market trends, and future outlook.
The ... |
|12/02/13||Prague-based Unimedis Acquired by ResMed|
|Deal will Increase Accessibility of Leading Sleep and Respiratory Therapies in Czech Republic
SAN DIEGO and PRAGUE, Dec. 2, 2013 /PRNewswire/ -- Prague-based Unimedis, a distributor of equipment for the treatment of sleep disordered-breathing in the Czech Republic and Slovakia, has been acquired by ResMed (NYSE: RMD), a pioneer and global leader in sleep and respiratory medicine.
"The Czech and Slovak markets have tremend... |
|11/20/13||ResMed Receives Injunctions against APEX and BMC in Germany, Continues Enforcement of Patents in Europe|
|Actions Filed in Germany to Stop Patent Infringement on Devices and Masks
DUSSELDORF, Germany, Nov. 20, 2013 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has won preliminary injunctions in Germany against several patent infringing activities by Taiwanese medical device manufacturer APEX Medical Corp. (APEX) and Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC). T... |
|10/24/13||ResMed Inc. Announces Record Financial Results For The Quarter Ended September 30, 2013|
|SAN DIEGO, Oct. 24, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record results for the quarter ended September 30, 2013. Revenue for the quarter ended September 30, 2013 was $357.7 million, a 5% increase (a 4% increase on a constant currency basis) over the quarter ended September 30, 2012. For the quarter ended September 30, 2013, net income was $80.9 million, an increase of 14% compared to the quarter ended September 30, 2012. Diluted earnings per share for the quarter ende... |